The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event
Abstract
The recently published CHAMPIONS trial1 reported that the early use of weekly IFN beta-1a (compared to delayed treatment) reduced the likelihood of developing clinically definite (CD) multiple sclerosis (MS) after a 5-year follow-up period in patients who had initially presented with clinically isolated syndromes (CIS) suggestive of MS. There are concerns both about the trial design and this conclusion. For example, this trial was planned only after the completion of the CHAMPS trial2 and with full knowledge of the CHAMPS results. Additionally, the primary endpoint of the CHAMPIONS trial was the development of CDMS at any time after CIS onset. Consequently, at the outset of CHAMPIONS, there was already a highly significant difference (bias) between groups with respect to the primary outcome measure. Significantly more patients in the delayed treatment group had already reached (and were known to have reached) their final endpoint before the trial even began compared to the early treatment group. Conversely, there were significantly more “survivors” (i.e., those without a second clinical …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Cited by
Hawker, K., O'Connor, P., Freedman, M. S., Calabresi, P. A., Antel, J., Simon, J., Hauser, S., Waubant, E., Vollmer, T., Panitch, H., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21867 · Cited by 934
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Bauer, L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61194-5 · Cited by 502
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E.-W., Metzig, C., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70237-6 · Cited by 369
Optical coherence tomography: a window into the mechanisms of multiple sclerosis
Frohman, E. M., Fujimoto, J. G., Frohman, T. C., Calabresi, P. A., Cutter, G., & Balcer, L. J. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0950 · Cited by 326
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
Kieseier, B. C. (2011) · CNS Drugs · doi:10.2165/11591110-000000000-00000 · Cited by 308
Metadata
- Authors
- Goodin, D. S.
- Venue
- Neurology
- Published
- 2006-09-26
- Volume
- 67
- Issue
- 6
- Pages
- 1104-1105
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2013902612
- Cited by
- 186
- References
- 1
- FWCI
- 13.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event. https://app.cochat.ai/papers/10.1212/01.wnl.0000240402.04846.6d
- The paper
- Goodin, D. S. (2006). IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology. https://doi.org/10.1212/01.wnl.0000240402.04846.6d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.